Search Clinical Trials
597,783 trials
ID
Status
Phase
Title
Sponsor
NCT07758309
Online Games to Help Canadian and U.S. Adults Identify COVID-19 and Vaccine Misinformation: Three Sequential Randomized StudiesCanadian HeritageCompletedNot Applicable
NCT07758309Completed
Not Applicable
Online Games to Help Canadian and U.S. Adults Identify COVID-19 and Vaccine Misi...Canadian Heritage
NCT07757776
A Prospective, Multicenter, Single-Arm Study to Support the Clinical Evidence Base for MRace as a Treatment Option for FMR Patients With Complex M-TEER Anatomies (DE)Polares Medical SANot Yet RecruitingNot Applicable
NCT07757776Not Yet Recruiting
Not Applicable
A Prospective, Multicenter, Single-Arm Study to Support the Clinical Evidence Ba...Polares Medical SA
NCT07758387
Polydextrose Functional Gummies for Weight Management in Adults With Overweight or ObesityNutris We Care About You S.L.Not Yet RecruitingNot Applicable
NCT07758387Not Yet Recruiting
Not Applicable
Polydextrose Functional Gummies for Weight Management in Adults With Overweight...Nutris We Care About You...
NCT07757594
FARES Versus Traction-Countertraction for Acute Anterior Shoulder DislocationNgoc Quyen LeNot Yet RecruitingNot Applicable
NCT07757594Not Yet Recruiting
Not Applicable
FARES Versus Traction-Countertraction for Acute Anterior Shoulder DislocationNgoc Quyen Le
NCT07758569
Validation of the Artificial Intelligence Subsystem of the DDART Medical Device for the Automated Detection of Lesions Compatible With Glaucoma in a Random Sample of Retinal Fundus PhotographsDemocritus University of ThraceRecruiting
NCT07758569Recruiting
—
Validation of the Artificial Intelligence Subsystem of the DDART Medical Device...Democritus University of...
NCT07757672
Salvage Chemotherapy With Sonrotoclax, Cladribine, and Standard-dose Cytarabine, Sequentially Followed by HSCT for R/R AML.Institute of Hematology & Blood Diseases Hospital, ChinaNot Yet RecruitingPhase 1
NCT07757672Not Yet Recruiting
Phase 1
Salvage Chemotherapy With Sonrotoclax, Cladribine, and Standard-dose Cytarabine,...Institute of Hematology &...
NCT07756736
Psilocybin Therapy for Methamphetamine Use Disorder and HIVNational Institute on Drug Abuse (NIDA)Not Yet RecruitingPhase 2
NCT07756736Not Yet Recruiting
Phase 2
Psilocybin Therapy for Methamphetamine Use Disorder and HIVNational Institute on Dru...
NCT07757555
Guanfacine and Cromolyn Sodium for POTS: The DBPOTS TrialDysautonomia InternationalNot Yet RecruitingEarly Phase 1
NCT07757555Not Yet Recruiting
Early Phase 1
Guanfacine and Cromolyn Sodium for POTS: The DBPOTS TrialDysautonomia Internationa...
NCT07757607
A Prospective, Multicenter, Single-Arm Study to Support the Clinical Evidence Base for MRace as a Treatment Option for FMR Patients With Complex M-TEER Anatomies (FR)Polares Medical SANot Yet RecruitingNot Applicable
NCT07757607Not Yet Recruiting
Not Applicable
A Prospective, Multicenter, Single-Arm Study to Support the Clinical Evidence Ba...Polares Medical SA
NCT07757165
The Necessity of Surgery in Patients With mGC Achieving Radiological Response After Conversion TherapyFudan UniversityRecruitingPhase 2
NCT07757165Recruiting
Phase 2
The Necessity of Surgery in Patients With mGC Achieving Radiological Response Af...Fudan University
NCT07756814
Manual Intervention and Congenital Hip Dysplasia in InfantsUniversité de SherbrookeNot Yet RecruitingNot Applicable
NCT07756814Not Yet Recruiting
Not Applicable
Manual Intervention and Congenital Hip Dysplasia in InfantsUniversité de Sherbrooke
NCT07757685
Autologous Hematopoietic Stem Cell Transplantation for Neurological Damage Associated With Hereditary Homocysteine Remethylation DisordersInstitute of Hematology & Blood Diseases Hospital, ChinaNot Yet RecruitingNot Applicable
NCT07757685Not Yet Recruiting
Not Applicable
Autologous Hematopoietic Stem Cell Transplantation for Neurological Damage Assoc...Institute of Hematology &...
NCT07758595
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL921 in Healthy Participants and Participants With Alzheimer's DiseaseDenali Therapeutics Inc.Not Yet RecruitingPhase 1
NCT07758595Not Yet Recruiting
Phase 1
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL921...Denali Therapeutics Inc.
NCT07758101
A Study to Evaluate the Safety of SHR-7590 in Chinese Healthy Participants and in Patients With Moderate-to-Severe Ulcerative ColitisGuangdong Hengrui Pharmaceutical Co., LtdNot Yet RecruitingPhase 1
NCT07758101Not Yet Recruiting
Phase 1
A Study to Evaluate the Safety of SHR-7590 in Chinese Healthy Participants and i...Guangdong Hengrui Pharmac...
NCT07758946
Endoexpedition - Use of a Serious Game to Deliver Patient Information and Decision Aid for Individuals With Endometriosis.Karolinska InstitutetNot Yet RecruitingNot Applicable
NCT07758946Not Yet Recruiting
Not Applicable
Endoexpedition - Use of a Serious Game to Deliver Patient Information and Decisi...Karolinska Institutet
NCT07757204
An Open-label Long-term Safety Study of Buntanetap in Participants With ADAnnovis Bio Inc.Not Yet RecruitingPhase 2
NCT07757204Not Yet Recruiting
Phase 2
An Open-label Long-term Safety Study of Buntanetap in Participants With ADAnnovis Bio Inc.
NCT07758829
Motor Cortex Stimulation for Post-Stroke Thalamic PainAerospace Center HospitalNot Yet RecruitingNot Applicable
NCT07758829Not Yet Recruiting
Not Applicable
Motor Cortex Stimulation for Post-Stroke Thalamic PainAerospace Center Hospital
NCT07758127
Updates and Insights on HER2 in Breast Cancer in Sohag GovernorateSohag Oncology CenterNot Yet Recruiting
NCT07758127Not Yet Recruiting
—
Updates and Insights on HER2 in Breast Cancer in Sohag GovernorateSohag Oncology Center
NCT07758855
Nanotechnological Silver-Coated Dressing in Diabetic Foot UlcersAnkara City Hospital BilkentCompletedNot Applicable
NCT07758855Completed
Not Applicable
Nanotechnological Silver-Coated Dressing in Diabetic Foot UlcersAnkara City Hospital Bilk...
Result Breakdown
Not yet recruiting15 (75%)
Recruiting3 (15%)
Completed2 (10%)
not_applicable10 (50%)
Not Specified3 (15%)
Phase 13 (15%)
Phase 23 (15%)
Early Phase 11 (5%)